You are here: Industry Insights > Positive

News List

Emergency Departments Need to Up HIV Testing, Linkage to Care drugs
September 24, 2019
HIV testing in South African emergency departments shows a high prevalence and incidence of HIV, as well as significant attrition along the HIV care cascade for HIV-positive individuals ...
Eppendorf AG with positive first half-year 2019 biospectrumasia
August 20, 2019
The globally active Eppendorf Group charted a strong first half-year in 2019 with a significant surge in Group sales to €378.5 million (prior year: €335.6 million). This positive development corresponds to an organic increase in sales of 12.8% (8.8% in lo
Ebola clinical trial stopped early due to positive results europeanpharmaceuticalreview
August 14, 2019
An Ebola clinical trial has been stopped early as Regeneron’s REGN-EB3 therapy shows superiority to ZMapp in preventing Ebola deaths.
TARIS Announces Positive Results of TAR-200 Trial americanpharmaceuticalreview
June 27, 2019
TARIS Bio™ announced positive safety, tolerability and preliminary efficacy data from the full patient cohort (n=20) of its Phase 1b study of TAR-200 for the treatment of patients with muscle invasive bladder cancer (MIBC), neoadjuvant to radical cystecto
Sound Pharmaceuticals Announces Positive Topline Results from SPI-1005 Phase 2b Trial americanpharmaceuticalreview
June 26, 2019
Sound Pharmaceuticals announced positive top-line results from a randomized, double-blind, placebo-controlled, multi-center Phase 2b study in Meniere's Disease (MD).
BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 americanpharmaceuticalreview
June 26, 2019
BioPharmX announced positive results from its Phase 2b clinical trial of BPX-041, a novel topical gel formulation of fully solubilized minocycline for the treatment of moderate-to-severe papulopustular rosacea.
TARIS Announces Positive Topline Data for TAR-302 americanpharmaceuticalreview
August 29, 2018
TARIS announced positive preliminary safety and efficacy data from its clinical study of TAR-302 for the treatment of patients with idiopathic overactive bladder (OAB) refractory to oral therapy.
Reapplix: Positive Outcome Data of Large Randomized Controlled Trial Presented at American Diabetes Association Scientific Sessions b3cnewswire
July 04, 2018
Reapplix ApS, the regenerative medicine company, initially focussed on chronic wounds, announces that positive outcome data of an independent Randomized Controlled Trial (RCT) of its LeucoPatch® wound healing platform was presented at the American Diabete
Nabriva Announces Positive Trial Results contractpharma
May 22, 2018
Nabriva Therapeutics announced positive topline results from its Lefamulin Evaluation Against Pneumonia (LEAP 2) clinical trial, the second of two global, pivotal Phase 3 clinical trials of lefamulin.